Pedim 2014 Final Scientific Programme

1

Final Programme

PEDIM 2014

Prague European Days of Internal Medicine18–20 September, 2014Prague, Czech Republic

Welcome to Prague!

2 3PEDIM 2014 Prague European Days of Internal Medicine18–20 September, 2014 PEDIM 2014Prague European Days of Internal Medicine

18–20 September, 2014

CONTENTSWELCOME LETTER 3

COMMITTEES 4

CONGRESS SECRETARIAT 4

CONGRESS VENUE 5

REGISTRATION 5

SOCIAL EVENT 6

INFORMATION FOR PARTICIPANTS 6

INFORMATION FOR SPEAKERS 7

ABSTRACTS 7

ON-SITE POSTER INSTRUCTIONS 8

CONGRESS VENUE MAP 9

PROGRAMME OVERVIEW 10

SCIENTIFIC PROGRAMME 12

– Thursday, September 18, 2014 12

– Friday, September 19, 2014 17

– Saturday, September 20, 2014 22

INDUSTRY SUPPORTED SYMPOSIUM 23

GENERAL INFORMATION 24

LIST OF POSTERS 25

PARTNERS 39

WELCOME LETTERDear Esteemed Colleagues and Friends,

Please allow me to cordially welcome you to Prague on behalf of the Organizing Committee of the Prague European Days of Internal Medicine (PEDIM) Congress. I assure you that we have done our utmost to ensure that your congress is both enlightening and enjoyable. That having been said, it is veritably impossible to organize such an event without encountering a few minor issues along the way. Should any arise, I do hope you will fi nd it possible to overlook them in light of our beautiful “City of a Hundred Spires.“ Prague has a very special atmosphere, which developed out of history, tradition, art, architecture, culture and a sense for the fi ner things in life. I trust that you will avail yourselves of this opportunity to experience the unique ambience of our city.

First and foremost, however, we have convened to deliberate matters pertaining to internal medicine, the very cornerstone of complex, integrated medical care. The objective of this congress is to improve the current state of health care in our countries. At present, it is characterized by an ageing population; metabolic, cardiovascular and other non-infectious disease epidemics; and is further compounded by diffi cult economic times. Treatment for this polymorbid population is available through various specialists and super-specialists whose integrated approach is supported by high-quality primary care systems that embrace super-specialized, costly care in precisely-defi ned situations.

In addition, the tremendous scientifi c benefi ts of plenary lectures, case reports, posters and other presentations will be invaluable.

I would also like to express my thanks and appreciation to the medical opinion leaders who graciously accepted our invitation to join the international organizing committee and advisory board.

A few years ago, some believed internal medicine to be a dying fi eld; one that had already been superseded by other branches of medicine. This is no longer the case: Internal medicine is not dying. Just as the mythical phoenix rose from its own ashes, so too has internal medicine and I fi rmly believe that PEDIM will provide more than suffi cient evidence to confi rm the continuing importance of our discipline.

I wish all of you a wonderful stay in Prague and I sincerely hope that PEDIM will prove to be an interesting, productive and unforgettable event for all of us.

Prof. Richard Ceska, MD, PhD, FACP, FEFIMPresident of the Czech Society of Internal MedicineCongress President, PEDIM 2014



COMMITTEESLocal Organising & Steering CommitteeRichard Ceska, Czech Republic – Congress President PEDIM 2014Jiri Widimsky jr., Czech Republic – Chair of Programme CommitteeMichal Vrablik, Czech Republic – Member of Organizing CommitteeMiroslav Soucek, Czech Republic – Member of Organizing CommitteeJindrich Spinar, Czech Republic – Member of Organizing Committee

International Organising & Steering CommitteePhilip Barter, Australia – President IASJean-Charles Fruchart, France – President R3iPeter M Nilsson, SwedenIvica Lazurova, SlovakiaDror Dicker, IsraelKlaus Parhofer, GermanyAntonio M. Gotto, USAHenry N. Ginsberg, USA

Supporting Societies

CONGRESS SECRETARIATGUARANT InternationalNa Pankraci 17, 140 21 Prague 4Czech Republic

Phone: +420 284 001 444Fax: +420 284 001 448E-mail: [email protected]

CONGRESS VENUEDiplomat Hotel PraguePublic transport: metro line A (green line), Dejvicka stationAddress: Evropska 15, 160 41 Prague 6, Czech Republic, www.diplomathotel.cz

REGISTRATIONRegistration FeesOn-site Fee (€)Delegates 480 €Young Internists (up to 35 years) 380 €

The registration fee includes:• Attending all Congress Scientifi c Sessions• Admission to the Exhibition Area and Poster Session• Final Programme, Abstract Book on CD and other congress materials• Coff ee breaks Registration opening hours on-siteWednesday, September 17 17:00–20:00Thursday, September 18 07:30–17:00Friday, September 19 08:30–17:00Saturday, September 20 08:30–13:00



INFORMATION FOR SPEAKERSHow to submit your presentation at the CongressPlease come to the Speakers´ Ready Room (Belvedere VI) at least 1 ½ hour before the beginning of your session. In case your speech has been scheduled for morning session please come to the Speakers´ Ready Room (Belvedere VI) one day before the day of your presentation.

Speakers´ Ready Room (Belvedere VI) location is marked in the fi nal programme brochure.

Opening hours of the Speakers Ready RoomWednesday, September 17, 2014 18:00–20:00Thursday, September 18, 2014 08:00–17:00Friday, September 19, 2014 08:00–17:00Saturday, September 20, 2014 08:30–12:00

• During your lecture you will be using Remote Control for controlling your presentation

• Your own notebook is allowed to use for presentation only after discussion with technician on-site

• All presentations will be deleted from all the PC used during the Congress• Please be in your Session room at least 15 minutes prior to the start of the Session• Make yourself known to the chairpersons and/or the room assistant (technician) in

your session room before the beginning of the session• You are kindly asked to keep your presentation within the given time limits, which

also include discussion time. The chairpersons of your session will be strict in allowing no more than the time allotted to your lecture: Remember to allow some time for the changeover of speakers and chairperson‘s introduction, and for questions and discussion

ABSTRACTSThe Prague European Days of Internal Medicine abstracts are available on CD as part of the congress materials.

SOCIAL EVENTGala dinnerDate: Thursday, September 18, 2014 Time: 19:00Place: CD Restaurant, Diplomat Hotel PraguePrice: 50 €

The Gala dinner will take place right at the congress venue. CD restaurant is situated on the ground fl oor of the Hotel Diplomat and we have prepared 3 course menu.

INFORMATION FOR PARTICIPANTSUEMS/EACCME CreditsWe are happy to announce that the Prague European Days of Internal Medicine was granted 14 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).

Feedback FormThe rules of the EACCME state that participants are kindly asked to fi ll in the feedback form included in the congress materials.

BadgesOnly participants who are wearing their name badge will be admitted to the lecture halls.



CONGRESS VENUE MAPON-SITE POSTER INSTRUCTIONSEach poster will be displayed for 2 days, on Thursday, September 18 and on Friday, September 19.

Posters can be displayed on their assigned board from 18:00 on Wednesday, September 17. Posters must be removed on Friday, September 19 no later than 18:00. Any posters remaining will be removed and destroyed and the congress will not keep any posters for later collection.

Poster mounting timesWednesday, September 17 18:00–20:00Thursday, September 18 07:30–09:00

Poster viewingThursday, September 18 09:00–17:00Friday, September 19 09:00–17:00

Poster removal timesFriday, September 19 17:00–18:00

Fixing material will be available at the Poster Area.



PROGRAMME OVERVIEW

Thursday, September 18, 2014 Thursday, September 18, 2014 Meeting Hall Prague Meeting Hall Belvedere

08:30–09:00Opening ceremony

Invasive cardiology [ ]

08:30–09:00

09:00–10:00Free communication

Case reports – Rare diseases09:00–10:00

10:00–11:00 Hypertension [ ] Free communicationCase reports – Infectious diseases / Rheumatology

10:00–11:00

11:00–11:30 Coff ee break Coff ee break 11:00–11:30

11:30–12:30Industry Sponsored Symposium

Hypertension and HyperuricemiaFree communication

Case reports – Gastroenterology / Endocrinology11:30–12:30

12:30–14:00 Break for lunch Break for lunch 12:30–14:00

14:00–15:00 Preventive cardiology – lipids – R3i [ ] Free communicationYoung internists

14:00–15:00

15:00–16:00Continuous

Coff ee break

Hot topics in internal medicine IFree communication

Cardiology 1

Continuous Coff ee break

15:00–16:00

16:00–17:00 Diabetes and metabolic syndrome [ ] Free communicationCardiology 2

16:00–17:00

Friday, September 19, 2014 Friday, September 19, 2014Meeting Hall Prague Meeting Hall Prague A Meeting Hall Belvedere

09:00–10:00 Nephrology SreenProFH* 1 09:00–10:00

10:00–11:00 Rare diseases SreenProFH* 2 10:00–11:00

11:00–11:30 Coff ee break Coff ee break 11:00–11:30

11:30–12:30Industry Sponsored Symposium

Dapaglifl ozin – beginning of a new era in the management of type 2 diabetes?

SreenProFH* 3 11:30–12:30

12:30–14:00 Break for lunch Break for lunch 12:30–14:00

14:00–15:00 Atherosclerosis [ ] Free communicationVaria 1

14:00–15:00

15:00–16:00Continuous

Coff ee break

Endocrinology [ ] Free communicationVaria 2

Continuous Coff ee break

15:00–16:00

16:00–17:00 Gastroenterology Free communicationCase reports – Varia

16:00–17:00

Saturday, September 20, 2014 MEETING Hall Belvedere

09:00–10:00 Rheumatology

10:00–11:00 Oncology

11:00–11:10 Coff ee break

11:10–12:10 Hot topics in internal medicine II

12:10–13:00 Closing ceremony

* ScreenPro is a screening project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe.

For Country representatives only.[ ] This session is being simultaneously translated into Russian. Please pick up your

translation headphones at the registration desk.



14:00–15:00 Preventive cardiology – lipids – R3i Chair: J. Ch. Fruchart (France)

J. Ch. Fruchart (France): Residual risk idea H. Ginsberg (USA): Statins, fi brates and diabetes mellitus K. Parhofer (Germany): Secondary hyperlipidaemias – focused on endocrine diseases R. Ceska (Czech Republic): Lomitapide in the treatment of LPL deffi ciency

15:00–16:00 Hot topics in internal medicine I Chair: M. Markova (Czech Republic)

R. Ceska (Czech Republic): New trends in treatment of dyslipidemias M. Markova (Czech Republic): Anemia

16:00–17:00 Diabetes and metabolic syndrome Chair: M. Fried (Czech Republic)

D. Dicker (Israel): Bariatric surgery for the diabetic patient – medical perspective M. Fried (Czech Republic): Bariatric surgery for the diabetic patient – surgeon perspective

SCIENTIFIC PROGRAMME

Thursday, September 18, 2014 Meeting Hall Prague

08:30–10:00 Opening Ceremony Invasive cardiology “Acute cardiology – Acute coronary syndromes” Chair: R. Rokyta (Czech Republic)

P. Widimsky (Czech Republic): Ongoing myocardial ischemia as criterion for early decision making M. Studencan (Slovakia): Slovak registry of ACS R. Rokyta (Czech Republic): Acute heart failure and cardiogenic shock

10:00–11:00 Hypertension Chair: P. M. Nilsson (Sweden)

P. M. Nilsson (Sweden): Hypertension and diabetes mellitus J. Filipovsky (Czech Republic): Pharmacological treatment of resistant hypertension J. Widimsky jr (Czech Republic): Nonpharmacological treatment of resistant hypertension


11:30–12:30 Industry Sponsored Symposium Hypertension and Hyperuricemia

J. Widimsky (Czech Republic): Treatment of hypertension with comorbidities J. Zavada (Czech Republic): Gout and the kidney

12:30–14:00 Break for lunch

15:00–16:00Continuous Coff ee break



11:30–12:30 Free communication Case reports – Gastroenterology / Endocrinology Chair: G. Taskin (Turkey)

J. Farrukh (Great Britain): Severe refractory coeliac disease with response only to parenteral

nutrition: a case report K. Ozturk (Turkey): A rare cause of ischemic colitis: colonoscopy G. Taskin (Turkey): A rare case; metronidazole-induced acute pancreatitis A. I. Pelaez Ballesta (Spain): Hypocalcemia and hypomagnesemia associated with proton pump

inhibitors


14:00–15:00 Free communication Young internists Chair: A. Andrieieva (Ukraine)

A. Andrieieva (Ukraine): Visfatin level in hypertensive patients with abdominal obesity against

the combination of antihypertensive therapy and atorvastatin A. Babich (Russia): Calcineurin inhibitors –induced arterial hypertension after liver

transplantation: single-center results. D. Abdulganieva (Russia): Evaluation of immune response to clostridium diffi cile in patients

with diff erent crohn‘s disease behavior A. Kerimkulova (Kazakhstan): The prevalence of selected cardiovascular disease in persons

exposed radiation due SNTS, Kazakhstan

Meeting Hall Belvedere

09:00–10:00 Free communication Case reports – Rare diseases Chair: A.R. Barbosa (Portugal)

C. Cardoso (Portugal): Spontaneous thoracic aortic rupture L. Guedes (Portugal): Hypokalaemia and metabolic alkalosis as presentation of ectopic

ACTH syndrome P. M. Azevedo (Portugal) Clinical challenges in the diff erential diagnosis of low back pain:

a case report A. R. Barbosa (Portugal): Coexistence of pernicious anemia and hashimoto‘s thyroiditis

in a 36 years old woman – a case report R. Meireles (Portugal): Sclerosing angiomatoid nodular transformation of the spleen –

a rare tumor

10:00–11:00 Free communication Case reports – Infectious diseases / Rheumatology Chair: P.M. Moniz (Portugal)

A. I. Pelaez Ballesta (Spain): Herpetic Encephalitis as secundary complication to

inmunosupression in patient with Multiple Myeloma T. Bernardo (Angola): Fever of unknown origin – massive infestation by ascaris

lumbricoides in pulmonary tuberculosis J. Cunha (Portugal): Multiple rare opportunistic diseases in an immunocompromised

patient with HIV: a case report P. M. Moniz (Portugal): Systemic sclerosis: obvious manifestations, late diagnosis




Friday, September 19, 2014 Meeting Hall Prague

09:00–10:00 Nephrology Chair: Z. Hruskova (Czech Republic)

M. Segelmark (Sweden): Diagnostic and prognostic tools in glomerular disease Z. Hruskova (Czech Republic): New modes of treatment in glomerular disease

10:00–11:00 Rare diseases Chair: V. Malinova (Czech Republic)

S. Moochhala (Great Britain): Fabry disease: nephrologist´s view L. Golan (Czech Republic): Fabry disease: cardiologist´s view V. Malinova (Czech Republic): Lysosomal storage diseases and morbus Gaucher – situation

in the Czech Republic


11:30–12:30 Industry Sponsored Symposium Dapaglifl ozin – beginning of a new era in the management

of type 2 diabetes?

M. Vrablik (Czech Republic): Antidiabetic treatment and CVD risk reduction: wishful thinking

or reality? D. Rahelic (Croatia): Why should diabetologist be interested in dapaglifl ozin? A. S. Lihn (Denmark): Dapaglifl ozin – practical implications


15:00–16:00 Free communication Cardiology 1 Chair: H. Rosolova (Czech Republic)

A. Kilianova (Czech Republic): Obstructive hyperthrophic cardiomyopathy and aortic valve disease

in elderly woman – a case for cathlab or surgery? H. Rosolova (Czech Republic): Residual cardiovascular risk in patients with stable coronary heart

disease over the last 16 years (Czech EUROASPIRE I-IV) A. I. Pelaez Ballesta (Spain): Infl uence of the 2011 Lorca earthquake on heart disease in the area V. Gafarov (Russia): Family stress in women and risk of myocardial infarction

and hypertension over 16 years in Russia: population-based MONICA-psychosocial study

16:00–17:00 Free communication Cardiology 2 Chair: M. Vrablik (Czech Republic)

B. I. Lopez Benjume (Mexico): Myocardial infarction risks factors in patients living in or outside

Mexico City V. Gafarov (Russia): Job stress eff ects on long-term risk of arterial hypertension and

myocardial infarction in female population aged 25-64 years in Russia

D. Balaziova (Slovakia): DNA diagnostics of familial hypercholesterolemia: Slovak experience M. Vrablik (Czech Republic): Atherosclerosis progression can be halted: an FH homozygote

without cardiovascular disease at the age of 40




Meeting Hall Prague A

09:00–10:00 ScreenPro FH* 1 Underdiagnosed, undertreated risk factor of CVD

How to diagnose FH How to fi nd FH How to screen FH

10:00–11:00 ScreenPro FH* 2 Screening Programes

Why to build international network Experience from MedPed MedPed in the Czech Republic


11:30–12:30 ScreenPro FH* 3 ScreenPro FH

Introduction of the ScreenPro FH What are our expectations How to participate in ScreenPro FH


* ScreenPro is a screening project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe.

For Country representatives only.

14:00–15:00 Atherosclerosis Chair: P. Barter (Australia)

P. Barter (Australia): Introduction. IAS FH Initiative. Why, Who and Where? K. Parhofer (Germany): Familial Hypercholesterolaemia A. M. Gotto jr (USA): Recent and future therapy of FH – focused on PCSK9-i, mipomersen

and lomitapide T. Freiberger (Czech Republic): MedPed network – the Czech experience

15:00–16:00 Endocrinology Chair: M. Krsek (Czech Republic)

W. M. Wiersinga (The Netherlands): Thyroid investigations in populations at risk to develop autoimmune

thyroid disease I. Lazurova (Slovakia): Adrenal incidentalomas P. F. Plouin (France): Primary aldosteronism – update

16:00–17:00 Gastroenterology “Current advances in clinical gastroenterology” Chair: M. Lukas (Czech Republic)

B. Pekarek (Slovakia): Progress in GI therapeutic endoscopy P. L. Lakatos (Hungary): New therapeutic modalities in IBD patients J. Martinek (Czech Republic): Role of PPIs in clinical practice in 2014 and beyond P. Papay (Austria): Evolving concept in colorectal cancer screening




16:00–17:00 Free communication Case reports – Varia Chair: A. A. Stan (Romania)

L. Costa (Portugal): A reversible cause of heart failure. Call for withdrawal A. A. Stan (Romania): Deep left internal jugular and subclavian vein thrombosis-rare cause

manifestation M. Nardi (Italy): Pioglitazone-induced lung damage I. Costa (Portugal): Spinal cord compression by vertebral metastases as the presenting

form of hepatocellular carcinoma

Meeting Hall Belvedere

14:00–15:00 Free communication Varia 1 Chair: C. Cardoso (Portugal)

C. Cardoso (Portugal): Trends in the use of non-invasive ventilation in a internal medicine

ward C. Mozzini (Italy): Endoplasmic reticulum stress and Nrf2 repression in circulating cells

of type 2 diabetic patients without the recommended glycaemic goals

E. V. Korneeva (Russia): Gender diff erences of metabolic syndrome among young people H. S. Gouveia (Portugal): Mid-upper arm circumference: an important weapon for nutritional

screening in hospitalized medical patients

15:00–16:00 Free communication Varia 2 Chair: Z. Chmelik (Czech Republic)

M. Petrova (Russia): Prevention of osteoporosis at North youth R. Serras Jorge (Portugal): Pneumocystis jirovecii pneumonia – 14 years of experience

in an intensive care unit H. S. Gouveia (Portugal): Diff erences in mortality of hospitalized patients under the age

of 65 – a two-year mortality assessment Z. Chmelik (Czech Republic): The eff ect of amaranth fl our on plasma cholesterol levels: another

option for cardiovascular risk lowering?


23PEDIM 2014Prague European Days of Internal Medicine18–20 September, 201422 PEDIM 2014 Prague European Days of Internal Medicine


Saturday, September 20, 2014 Meeting Hall Belvedere

09:00–10:00 Rheumatology Chair: J. Lukac (Slovakia)

J. Vencovsky (Czech Republic): Immune mediated necrotising myopathy J. Zavada (Czech Republic): New recommendations for diagnosis and treatment of gout K. Pavelka (Czech Republic): Therapeutic strategies in therapy of diff erent forms

of spondyloarthritides J. Lukac (Slovakia): Modern diagnostic and therapeutic approaches in scleroderma

10:00–11:00 Oncology Chair: R. Gurlich (Czech Republic)

F. Lordick (Germany): New targeted drug prolongs survival in advanced stomach cancer R. Gurlich (Czech Republic): Surgical management of gastric cancer


11:10–12:10 Hot topics in internal medicine II Chair: M. Krsek (Czech Republic)

M. N. Mamedov (Russia): Men health’s problems in cardiology M. Krsek (Czech Republic): When and how to screen patients for Cushing´s syndrome V. Hainer (Czech Republic): New antiobesity drugs

12:10–13:00 Closing Ceremony

INDUSTRY SUPPORTED SYMPOSIUMThursday September 18, 11:30–12:30, Meeting room PragueSatellite Symposium supported by Berlin-ChemieHypertension and HyperuricemiaJ. Widimsky (Czech Republic): Treatment of hypertension with comorbitiesJ. Zavada (Czech Republic): Gout and the kidney

Friday, September 19, 11:30–12:30, Meeting room PragueSatellite Symposium supported by Astra ZenecaDapaglifl ozin (Forxiga) – beginning of a new era in the management of type 2 diabetes?Michal Vrablik (Czech Republic): Antidiabetic treatment and CVD risk reduction: wishful thinking or reality?Dario Rahelic (Croatia): Why should diabetologist be interested in dapaglifl ozin?Aina S. Lihn (Denmark): Dapaglifl ozin – practical implications



GENERAL INFORMATIONPublic TransportPlease note – All registered participants will receive Free PUBLIC TRANSPORT TICKET (received on-site at the registration desk and will be valid within the dates of the congress).

Prague has a very sophisticated subway, tram and bus transport system. The PragueUnderground is quite new and effi cient. At peak times, trains run every 2 or 3 minutes, and during off -peak hours at least every 8–10 minutes.

Taxi ServiceIn the city centre, taxis are easy to hire from the street but we strongly recommend you to use hotel taxis or to call a taxi by phone through the radio taxi service.

We recommend you to use following taxi companies:Profi Taxi +420 261 314 151 or +420 14 0 15AAA Taxi +420 222 333 222 or +420 14 0 14

InsuranceThe organizers do not accept responsibility for individual medical, travel or personal insurance. All participants are strongly advised to take out their own personal insurance before travelling to the Convention.

Currency & BankingCzech crown (CZK) is the offi cial currency of the Czech Republic. Exchange of foreign currency is available at Prague international Airport and at most hotels, banks and exchange offi ces throughout the city. International credit cards are accepted for payments in hotels, restaurants and shops. Payment in cash in EUR is also available in some restaurants and shops, please ask for details on-site. You can fi nd the offi cial exchange rates on the website of the Czech National Bank at www.cnb.cz.

ShoppingMost shops in Prague are open from 9:00 to 18:00, Monday to Saturday. Shops in the city centre are usually open from 9:00 to 20:00, Monday to Sunday.

Useful telephone numbers112 – General Emergency for Europe150 – Fire alarm155 – Ambulance156 – Prague Police158 – State Police

LIST OF POSTERSLegendID Title of the poster Name of the author / authors

POSTERSNoninvasive cardiology13 Diagnostic value of galectin-3 in patients with Heart Failure K. Gyamdjyan, M. Maximov

15 Certain determinants of quality of life in patients with chronic heart failure of ischemic origin

M. Vatutin, M. Khrystychenko, O. Kieting, A. Zagoruiko

25 R wave amplitude of aVL derivation seems to be important in predicting arterial stiff ness parameters

H. Sarlak, F. Bulucu, E. Arslan, S. Demirbas, M. Akhan, S. Demirkol

44 Short training in focused cardiac ultrasound in an Internal Medicine department: what realistic skill targets could be achieved?

C. Mozzini, L. Cominacini, A. Fratta Pasini

66 Early and long-term cardiovascular complications after orthotopic liver transplantation.

A. Babich, E. Kosmacheva

111 Impact of Framingham Risk Score, Flow-Mediated Dilation, Pulse Wave Velocity, and Biomarkers for Cardiovascular Events in Stable Angina

K. H. Park, W. J. Park, S. J. Han, H. S. Kim, S. H. Jo, S. A. Kim

112 Osteoprotegerin Gene Polymorphism Is Not Associated With Angiographic Coronary Artery Stenosis and Calcifi cation in Korean

W. J. Park, K. H. Park, H. S. Kim, S. H. Jo, S. A. Kim

113 Urinary NGAL levels in patients with acute and chronic heart failure M. Dankova, T. Pazmanova, J. Gergel, I. Gaborikova, P. Pontuch

128 Outcomes of lesions with positive remodeling using coronary multi-detector row computed tomography (MDCT) data analysis

S. U. Kwon

131 Levosimendan use in the intensive care patient and its impact on renal and hepatic function

J. R. Pereira



135 Outcome after treatment with Levosimendan according to the etiology of heart failure - the perspective of an Intensive Care Unit

J. R. Pereira

Hypertension23 Dipping Status in Individuals Monitored by Ambulatory Blood Pressure

Measurements H. Sarlak, F. Bulucu, E. Arslan, S. Demirbas, K. Saglam

68 Does it only reduction of arterial pressure determines the eff ectiveness of antihypertensive pharmacotherapy?

O. Kompaniets, A. Ponomareva, V. Pokrovskii

81 Diastolic function of the left and right ventricles in hypertensive patients A. Kerimkulova, A. Markabayeva, T. Rakhypbekov, L. Pivina

129 Current status of hypertension in Korean people: data from a heart day campaign

S. U. Kwon

Gastroenterology16 Detection of Colorectal Neoplasm using promoter methylation of stool

DNA in Korean patients J. H. Yoo, D. I. Park

30 The relationship of metabolic disorders and severity of liver disease with gene polymorphism ?2- adrenergic receptor in chronic hepatitis C

I. A. Bulatova, A. P. Schekotova, N. I. Nasibullina, V. V. Shchekotov

42 Polymorphism eNOS3 (rs1799983) gene and its relationship with the severity of infl ammation in chronic hepatitis C and ulcerative colitis

I. A. Bulatova, Y. I. Tretyakova, V. V. Shchekotov, A. P. Schekotova

51 Effi ciency of Rifampicin in Emergency Treatment of Severe Intrahepatic Cholestasis

K. Ozturk, H. Demirci, Y.S. Sakin, A. Uygun, S. Bagci

67 Pulse Wave Velocity in Patients with Normotensive and Normoglysemic Ulcerative Colitis

K. Ozturk, M. Gulsen, A.K. Guler, M. Cakir, S. Demirbas, M. Gezer, H. Demirci, Y. S. Sakin, A. Uygun, S. Bagci

70 MEFV gene mutation frequency in patients with acute pancreatitis and its clinical importance

G. Taskin, S. Sayin, B. Koc, D. Torun, G. Buyukturan, E. Arslan, Y. Tunca, K. Saglam

Haematology32 Changes in platelet count in an internal medicine ward D. Barchel, I. Tzur, M. Shteinshnaider, D. Almoznino-Sarafi an, N. Tsatsanashvili,

M. Swarka, N. Cohen, O. Gorelik

76 Non-Hodgkin’s lymphoma diff use large B cell patients in more than 80 years old

K. Natori, D. Nagase, S. Ishihara, A. Sakai, M. Kato, Y. Kuraishi, H. Izumi

77 Multiple neoplasms consist of esophangeal cancer and hematological malignancy

K. Natori, S. Ishihara, D. Nagase, A. Sakai, M. Kato, Y. Kuraishi, H. Izumi

96 Venous thromboembolic prophylaxis; is decision making consistent A. Salam, M. Haji-Coll, C. Lisk

Infectious diseases33 Rare case of constrictive pericarditis due to combined Actinomyces-

Fusobacterium infection I. Tzur, I. Reznick, D. Almoznino-Sarafi an, M. Shteinshnaider, N. Cohen, O. Gorelik

53 Levofl oxacin induced proximal miopathy L. Tiosano, J. Bathish, G. Buzarov, A. Zeidman

56 Diagnosis and treatment of Chlamýdia trachomatis infection- case report E. Janekova, P. Ziak

57 Acute Q fever: Description of two cases with atypical presentation E. Papadimitriou, A. Masgala, E. Karabousli, M. Kalyvas, L. Lanaras

58 Pneumococcal Septic polyarthritis revealing smoldering myeloma A. Silawy, G. Lavie, S. Perek, D. Zisman, G. Weber, S. Cohen

59 Endogenous endophthalmitis as the presenting symptom of klebsiella pneumonia bacteremia of urinary origin – rare complication of common disease

G. Lavie, A. Zoabi, G. Weber, S. Cohen

62 An unusual case of afebrile endocarditis presenting as purpura and acute renal failure

G. Lavie, A. Silawy, G. Weber, S. Cohen

100 Pandemic h1n1 infl uenza vs seasonal infl uenza – a dangerous virus today?

M. J. Anaya, P. Azevedo, J. Patrocinio, E. Leite, F. Aldomiro



101 Kidney and vertebral tuberculosis C. Madaleno, N. Jacinto, G. Vieira, P. Rocha, J. Meneses Santos

110 Enteric Parasites in Children from São Tomé and Príncipe: a Window for Prevention

J.B. Augusto, M.L. Lobo, J. Ceita, O. Matos

121 Active tuberculosis in patients over 65 J. Nieto-LopezGuerrero, J. F. Pascual-Pareja, M. Martinez-Prieto,

R. Carrillo-Gomez, C. Garcia-Cerrada, A. Noguerado-Asensio

136 Are we using sharps bins appropriately? M. Haji-Coll, J. Olatujoye, C. Huang, C. Lisk

Various40 Malignant fi brous histiocytoma in the heart; autopsy case S. Furukawa, S. Morita, K. Nishi, M. Hitosgugi

48 The Associated Between Pulse Wave Velocity and Mean Platelet Volume in Patients with Infl ammatory Bowel Disease

M. Gezer, M. Cakir, A.K. Guler, T. Dogan, K. Ozturk

126 Antithrombotic therapy prescription for the prevention of stroke: patterns of underuse in Krasnodar patients with atrial fi brillation

A. Ponomareva, O. Kompaniets, R. Linchak, L. Prutskaya, Y. Saibel

29 Diabetes care in hemodialysis patients; what can we improve Z. Dimitrijevic, K. Paunovic, M. Stojanovic, J. Kostic, S. Ljubenovic

114 A New Opinion on the Etiopathogenesis of RLS and Sleep Disorders in Patients Undergoing Chronic Dialysis: Infl ammation

A. Acay, A. Ahsen, M. S. Ulu, S. Oruc, M. Sariaydin, S. Yuksel, G. Acarturk

61 Measurement of random capillary blood glucose at admission J. Green, H. Dadds, M. Hajj-coll, R. Garg, P. Jacobs

11 Prerequisites for the comprehensive evaluation of patients with gout in Yakutia

M. Petrova

18 Chalanges in treating a patient with psoriathic arthropaty and hepatic involvement

M. P. Duna, V. C. Bojinca, R. Ionescu

36 Service improvement project investigating neutropenic sepsis admissions at barnet general hospital

C. Tang, M. Haji-Coll, P. Jacobs

93 Multiple myeloma - series of diff erent clinical presentations V. Carapichoso, T. Monteiro, A. Abreu, N. Andrade, A. Obregon, M. Neto

102 Mucoepidermoid carcinoma of the salivary gland - a clinical challenge M. J. Anaya, P. Azevedo, J. Patrocinio, E. Leite, F. Aldomiro

38 Pseudopheocromocytoma a rare case of refractory hypertension L. Frade, A. Ribeiro Cunha, L. Costa, M. Miguens, L. Campos

10 Results of a multi-centre audit to improve doctors‘ awareness of DVLA guidelines

M. Maruthappu, J. Farrukh, B. Green, T. Soomro, N. D. Gollop, R. A. Watson, J. C. R. Wormald, M. Park, J. Shalhoub, K. Y. B. Ng

45 Alcohol use and drinking motives among Korean medical students S. Y. Lee

46 Dignity of death and quality of end-life process G. Lara Martinez, A. I. Pelaez Ballesta, M. M. Molina Morales, V . Martínez Pagán,

M. Miluy Guerrero, F. Escobar Gomez-Villalba, E. Mene Fenor

72 Hyponatremia in critically ill patients L. Yamanel, G. Taskin, M. Eser, A. Kilinc, K. Kara, E. Tekgoz, N. G. Somak

86 Frailty syndrome and hopitalization time in an internal medicine department - a prospective observational study

A. R. Barbosa, A. R. Ramos, O. Gonçalves, V. Paixão

98 Venous thromboembolism prophylaxis in an Internal Medicine Ward R. Meireles, I. Costa, D. Ferreira, V. Iglesias, P. Baptista

120 A less common iatrogenic complication of unpredictable end L. Costa, F. Marques, A. Botella, D. Romeira, P. Moniz, A. Leitão, C. Fonseca,

F. Ceia

124 Screening examination of the Kazakhstan population exposed to radiation

A. S. Kerimkulova, L. M. Pivina, T. I. Belikhina, A. M. Markabaeva, T. K. Rakhypbekov, K. N. Apsalikov, A. K. Akhmetova, Z. Yensegenova



130 The anti-infl ammatory eff ect of pulmonary renin angiotensin system blockade by intratracheally administered losartan

I. L. Gurzu, L. G. Vata, E. Cojocaru, D. Ungureanu, F. Mitu, B. Gurzu

134 Computerized tomography before lumber puncture for suspected CNS infection – not always necessary and causing delays?

H. Ahmed, P. Glynne, A. Morin

139 The junior vision about safety culture I. B. Mesquita, J. A. Monteiro, M. Pires, L. Carvalho, A. Pereira

Case Reports105 Resistant hypertension and RSD: is it possible to foresee

a non-responder patient? F. Cagnoni, G. P. Dognini, S. Panza, E. Gorla, A. Besozzi, A. Belotti Masserini,

P. Colombelli, V. Galimberti, C. Cavalleri, M. Destro

90 Extraganglionar lymphoma - a clinical case T. Bernardo, E. Freitas, V. Carapichoso, A. Abreu, N. Andrade, M. Neto

127 Kearns-Sayre Syndrome: The integrative role of internal medicine specialists

E. Cagiltay, F. Akay, S. Toyran, M. Atalay, A. Bakir

95 Peritoneal tuberculosis - from diagnosis to treatment V. Carapichoso, J. Chivia, E. Freitas, T. Bernardo, A. Abreu, N. Andrade, M. Neto

99 Retroperitoneal hematoma: a diff erential diagnosis to keep in mind C. Madaleno, N. Jacinto, F. Trigueiros, A. J. Pedro, J. Meneses Santos

138 Orbital infl ammatory pseudotumor as fi rst manifestation of a breast lobular carcinoma

V. Martinez Pagan, A. Pelaez Ballesta

LAST MINUTE POSTERSHypertension145 Comparison the incidence of top ten types of cancers among Iraqi

population before and after the 3rd Gulf war 2003 S. Ali - Sadiam H. + Ali

Noninvasive cardiology146 Blood pressure and blood pressure variability: implications, challenges,

and perspectives E. V. Pello, S. K. Malyutina, E. G. Verevkin, G. I. Simonova, Y. P. Nikitin

Various147 Discharge summaries audit: Is secondary care communicating safely

and accurately back to primary care? H. Ahmed, S. Savla, M. Hogan, A. Radia, S. Mitchell

Clinical Biochemistry148 Correlation between hypernatremia severity and patients ages on icu

admission G. Taskin, M. Eser, K. Kara, N. G. Somak, A. Kilinc, L. Yamanel

Infectious diseases149 A rare case of secondary vasculitis M. J. Anaya, P. M. Azevedo, J. Patrocínio, E. Leite, F. J. Aldomiro

Rheumatology150 How to improve early diagnosis of axial spondyloarthritis (according

to Rheumatologic city Center, Kazan, Russia) S. A. Lapshina, L. I. Myasoutova, Sh. F. Erdes

151 10-year probability of osteoporotic fracture using FRAX program A. G. Vasilyev, D. I. Abdulganieva, L. I. Myasoutova

152 Eff ectiveness of educational activities for patients with osteoporosis L. I. Myasoutova, S. A. Lapshina



NOTES



39PEDIM 2014Prague European Days of Internal Medicine18–20 September, 2014

PARTNERSThe organizing committee would like to thank to all partners

for their strong support!

Silver Partner

Bronze Partners

Partners

Media Partners

Poorly controlled LDL-C continuesto loom over millions of lives1

Despite treatment with statins, millions of high-risk patients with hypercholesterolemia in the US continue to have poorly controlled LDL-C and are at persistent cardiovascular risk.2

Sanofi and Regeneron are committed to providing resources to better understand cholesterol management and to research the unmet needs of patients with poorly controlled LDL-C.

LDL-C = low-density lipoprotein cholesterol.

References: 1. Pöss J, Custodis F, Werner C, Weingärtner O, Böhm M, Laufs U. Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des. 2011;17:861-870. 2. Jones PH, Nair R, � akker KM. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis. JAHA. 2012;1:1-10. doi:10.1161/JAHA.112.001800.

©2014, Sanofi and Regeneron Pharmaceuticals, Inc. | CZ.MTB.14.08.05

sanofi –aventis, s.r.o., Evropská 846/176a, 160 00 Praha 6, tel.: 233 086 111, fax: 233 086 222, www.sanofi .cz

REGENERONGoing beyond today

Molekuly_A5_EN_01_TISK.indd 1 25.8.2014 10:26:34

CONGRESS SECRETARIATGUARANT International spol. s r. o.Na Pankraci 17, 140 21 Prague 4Czech RepublicTel: +420 284 001 444E-mail: [email protected]

WWW.PEDIM2014.ORG

PEDIM 2014

Health & Medicine

Pedim 2014 Final Scientific Programme